-
Collaboration to establish comprehensive pharma, health system
biospectrumasia
May 29, 2019
111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System
-
Trovagene Announces Collaboration with Nektar to Evaluate Onvansertib, ONZEALD™
americanpharmaceuticalreview
May 24, 2019
Trovagene and Nektar have entered into a research collaboration to explore the combination of Trovagene's PLK1 inhibitor, onvansertib, and Nektar's topoisomerase I inhibitor, ONZEALD ...
-
Gilead and insitro Ink Drug Discovery Deal
April 24, 2019
Gilead Sciences and insitro have entered into a strategic collaboration to discover and develop therapies for patients with nonalcoholic steatohepatitis (NASH).
-
PureTech Health Announces Collaboration with Boehringer Ingelheim
pharmafocusasia
April 19, 2019
PureTech Health Announces Collaboration with Boehringer Ingelheim
-
Charles River & CHDI Extend Partnership
contractpharma
April 15, 2019
Five-year extension of their ongoing collaboration that started in 2005 for the drug discovery and development for Huntington’s disease...
-
Xencor and Astellas Enter Collaboration for Novel Bispecific Antibody Program
pharmafocusasia
April 03, 2019
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, today announced it has entered into a research and license agreement in...
-
HitGen & Almirall Enter Research Collaboration
contractpharma
March 27, 2019
HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for Almirall.
-
Exscientia Launches New Subsidiary
March 27, 2019
Exscientia K.K will spearhead the company's pharmaceutical interests across Asia.
-
Enamine, Lundbeck Extend Drug Discovery Pact
contractpharma
March 27, 2019
Enamine will support Lundbeck’s in-house discovery chemistry competencies with three principal assets
-
China’s HitGen in collaboration with India’s Sun Pharma to identify small molecule leads
fiercepharma
March 18, 2019
Chinese biotech HitGen has inked a new collaboration deal with India’s Sun Pharma Advanced Research arm aimed at seeking out new small molecule leads.